Patient_Reported_Outcome_Measures_in_Rheumatic_Diseases

(ff) #1

208



  1. Boomershine CS, Emir B, Wang Y, Zlateva G. Simplifying fi bromyalgia assessment: The
    VASFIQ brief symptom scale. Ther Adv Musculoskelet Dis. 2011;3(5):215–26.

  2. Fries JF. The hierarchy of quality-of-life assessment, the health assessment questionnaire
    (HAQ), and issues mandating development of a toxicity index. Control Clin Trials. [Research
    Support, U.S. Gov’t, P.H.S.]. 1991;12(4 Suppl):106S–117S.

  3. Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L. The assessment of
    functional impairment in fi bromyalgia (FM): Rasch analyses of 5 functional scales and the
    development of the FM health assessment questionnaire. J Rheumatol. [Evaluation Studies].
    2000;27(8):1989–99.

  4. El Miedany Y, El Gaafary M, Youssef S, El Aroussy N, Ahmed I, Palmer D. Towards a multi-
    dimensional patient reported outcome measures assessment: Development and validation of a
    questionnaire for patients with fi bromyalgia. EULAR: Ann Rheum Dis. 2013;72 Suppl 3:719.

  5. Cuesta-Vargas A, Luciano JV, Penarrubia-Maria MT, Garcia-Campayo J, Fernandez-Vergel R,
    Arroyo-Morales M, et al. Clinical dimensions of fi bromyalgia symptoms and development of
    a combined index of severity: the CODI index. Qual Life Res. [Research Support,
    Non- U.S. Gov’t]. 2013;22(1):153–60.

  6. Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, et al. The development
    and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12(4):
    276–85.

  7. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN
    study reached international consensus on taxonomy, terminology, and defi nitions of measure-
    ment properties for health-related patient-reported outcomes. J Clin Epidemiol.
    2010;63(7):737–45.

  8. Rivera J, Gonzalez T. The fi bromyalgia impact questionnaire: a validated spanish version to
    assess the health status in women with fi bromyalgia. Clin Exp Rheumatol. [Clinical Trial
    Randomized Controlled Trial Validation Studies]. 2004;22(5):554–60.

  9. Ablin JN, Odes L, Neumann L, Buskila D. The Hebrew version of the fi brofatigue scale: vali-
    dation of a questionnaire for assessment of fi bromyalgia and chronic fatigue syndrome.
    Rheumatol Int. [Validation Studies]. 2010;30(9):1173–6.

  10. Finckh A, Morabia A, Deluze C, Vischer T. Validation of questionnaire-based response criteria
    of treatment effi cacy in the fi bromyalgia syndrome. Arthritis Care Res. 1998;11(2):116–23.

  11. Sarzi-Puttini P, Atzeni F, Turiel M, Furlan R, Vulpio L, Carrabba M, et al. The Italian version
    of the fi brofatigue scale, a reliable tool for the evaluation of fi bromyalgia symptoms.
    J Psychosom Res. [Validation Studies]. 2004;56(2):213–6.


L. Carmona et al.
Free download pdf